Focus 01 January 2014

Anti-cancer therapies

Cell Death & Disease is delighted to announce it has published its 1000th article:

The traditional Chinese medical compound Rocaglamide protects non-malignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression

To mark this achievement, we have published the following web focus from Cell Death & Disease and Cell Death & Differentiation on anti-cancer therapies.

We hope you enjoy this focus including work from the world's most recognized experts in the field of anti-cancer therapies.

From Cell Death & Disease

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis
- A Pujals
- B Renouf
- J Wiels
Original ArticleOpen Access28 Jul 2011 Cell Death & Disease
Mitosis-targeted anti-cancer therapies: where they stand
- K-S Chan
- C-G Koh
- H-Y Li
ReviewOpen Access18 Oct 2012 Cell Death & Disease
Many faces of DAMPs in cancer therapy
- O Krysko
- T Løve Aaes
- D V Krysko
ReviewOpen Access16 May 2013 Cell Death & Disease
Human Gyrovirus Apoptin shows a similar subcellular distribution pattern and apoptosis induction as the chicken anaemia virus derived VP3/Apoptin
- J Bullenkamp
- D Cole
- M Tavassoli
Original ArticleOpen Access12 Apr 2012 Cell Death & Disease
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells
- S Belluti
- V Basile
- C Imbriano
Original ArticleOpen Access8 Aug 2013 Cell Death & Disease
Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells
- V KW Wong
- T Li
- L Liu
Original ArticleOpen Access11 Jul 2013 Cell Death & Disease

From Cell Death & Differentiation

BCL2A1: the underdog in the BCL2 family
- M Vogler
Review11 Nov 2011 Cell Death & Differentiation
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis
- E Kerr
- C Holohan
- D B Longley
Original Paper10 Feb 2012 Cell Death & Differentiation
CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma
- J Tang
- Y-S Guo
- Z-N Chen
Original Paper18 May 2012 Cell Death & Differentiation
PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death
- E-M Schweikert
- A Devarajan
- S Horke
Original Paper23 Mar 2012 Cell Death & Differentiation
Systems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells
- E Passante
- M L Würstle
- M Rehm
Original Paper9 Aug 2013 Cell Death & Differentiation
FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis
- R van Boxtel
- C Gomez-Puerto
- P J Coffer
Original Paper5 Jul 2013 Cell Death & Differentiation

Anti-cancer therapies

From Cell Death & Disease

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis

Mitosis-targeted anti-cancer therapies: where they stand

Many faces of DAMPs in cancer therapy

Human Gyrovirus Apoptin shows a similar subcellular distribution pattern and apoptosis induction as the chicken anaemia virus derived VP3/Apoptin

Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells

Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells

From Cell Death & Differentiation

BCL2A1: the underdog in the BCL2 family

Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis

CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma

PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death

Systems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells

FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis

Search

Quick links